1 year return (CAGR)
362.62%
Relay Therapeutics Inc Exchange (NASDAQ, USD)
RLAY
19.06
+0.19 (+1.01%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
23.82%
5 year return (CAGR)
-9.56%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.18B
Price/Sales
403.56
Ent value
4.13B
Price/Book
4.69
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
5.55%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 18.95 |
| Daily high | 19.43 |
| Daily low | 18.88 |
| Daily Volume | 2.40M |
| All-time high | 61.53 |
| 1y analyst estimate | 27.08 |
| Beta | 1.70 |
| EPS (TTM) | -1.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| RLAY | S&P500 | |
| Current price drop from All-time high | -69.02% | -2.19% |
| Highest price drop | -96.75% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -69.13% | -10.69% |
| Avg time to new high | 111 days | 12 days |
| Max time to new high | 1417 days | 1805 days |
News
